Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
NOAH Stock Summary
Top 10 Correlated ETFs
NOAH
In the News
These 5 Price-to-Sales Stocks Can Be Rewarding Investments
The price-to-sales ratio is a convenient tool to gauge the value of stocks incurring losses or in an early development cycle. Stocks like PAGS, BCC, NOAH, AVA and FHN hold promise.
5 Value Stocks With Impressive EV-to-EBITDA Ratios to Scoop Up
We have screened value stocks AZZ, HTLF, CX, NOAH and ASX based on the EV-to-EBITDA ratio, which offers a clearer picture of valuation and earnings potential.
Are Investors Undervaluing Noah Holdings (NOAH) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Tap These 5 Bargain Stocks With Attractive EV-to-EBITDA Ratio
We have screened bargain stocks KT, PK, CVE, FHN and NOAH based on the EV-to-EBITDA ratio, which offers a clearer picture of valuation and earnings potential.
Noah Holdings: Watch New Capital Return Framework And Insurance Products
NOAH has decided to raise its minimum dividend payout ratio from 10% earlier to 35% going forward. Noah Holdings' insurance fee income derived from its international insurance business operations grew by +381.8% YoY in the first nine months of this year. I make no changes to my existing Buy rating for NOAH, as I like its new shareholder capital return policy and I have a favorable opinion of insurance product demand.
Noah Holdings: Consider Overseas Expansion And Financial Strength
NOAH aims to grow its number of relationship managers in Hong Kong and Singapore to 120 by the end of the current year to support its overseas expansion efforts. NOAH's credit ratios are reasonably healthy, and this means that the company has the financial capacity to increase its future dividend distributions. I stick to my existing Buy investment rating for Noah Holdings, as I have a positive view of its overseas expansion plans and strong financial position.
Noah Holdings Limited (NOAH) Q2 2023 Earnings Call Transcript
Noah Holdings Limited (NYSE:NOAH ) Q2 2023 Results Conference Call August 28, 2023 8:00 PM ET Company Participants Melo Xi - Director, IR Wang Jingbo - Co-Founder, Chairlady and CEO Grant Pan - CFO Conference Call Participants Chiyao Huang - Morgan Stanley Peter Zhang - JP Morgan Operator Good day, and welcome to the Noah Holdings Second Quarter 2023 Earnings Conference Call. [Operator Instructions] I would now like to turn the conference over to Melo Xi, Director of Investor Relations.
Staying Bullish On Noah Holdings
NOAH's 2023 financial prospects are healthy, taking into account expectations of double-digit revenue growth and net margin expansion. Specifically, Noah Holdings' Hong Kong office has witnessed a growing interest in its insurance product offerings from Mainland Chinese customers. My Buy rating for NOAH remains intact, as the stock's depressed valuations don't do justice to its favorable near-term outlook.
Noah Holdings Limited (NOAH) Q1 2023 Earnings Call Transcript
Noah Holdings Limited (NYSE:NOAH ) Q1 2023 Results Conference Call May 30, 2023 8:00 PM ET Company Participants Melo Xi - IR Wang Jingbo - CEO Grant Pan - CFO Conference Call Participants Helen Lee - UBS Chiyao Huang - Morgan Stanley Melo Xi Good morning, everyone, and welcome to Noah's 2023 First Quarter Earnings Call. I'm Melo Xi, Director of Investor Relations at Noah Group.
Noah Holdings Limited (NOAH) Q4 2022 Earnings Call Transcript
Noah Holdings Limited (NYSE:NOAH ) Q4 2022 Earnings Conference Call March 27, 2023 5:30 PM ET Company Participants Melo Xi - IR Jingbo Wang - Chair, President & CEO Qin Pan - CFO Conference Call Participants Operator Hi, good morning, everyone and welcome to Noah's Fourth Quarter and Yearend Conference Call. I'm Melo Xi, Director of Investor Relations in Noah Group.
NOAH Financial details
NOAH Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 48.26 | 55.46 | 53.28 | 63.91 | 45.37 | |
Net income per share | 13.02 | 13.56 | -13.6 | 14.95 | 14.29 | |
Operating cash flow per share | 17.57 | 21.06 | 12.84 | 22.66 | 9.26 | |
Free cash flow per share | 15.38 | 19.99 | 12 | -11.16 | 8.34 | |
Cash per share | 53.85 | 82.71 | 82.53 | 52.07 | 69.07 | |
Book value per share | 105.42 | 128.76 | 117.3 | 121.21 | 137.65 | |
Tangible book value per share | 105.42 | 128.76 | 117.3 | 121.21 | 139.03 | |
Share holders equity per share | 105.42 | 128.76 | 117.3 | 121.21 | 137.65 | |
Interest debt per share | 2.89 | 6.13 | 5.78 | 3.31 | 0.18 | |
Market cap | 17.45B | 15.05B | 19.36B | 13.14B | 7.3B | |
Enterprise value | 14.89B | 11.03B | 14.62B | 9.86B | 3.07B | |
P/E ratio | 22.87 | 18.16 | -22.94 | 13.08 | 7.48 | |
Price to sales ratio | 6.17 | 4.44 | 5.86 | 3.06 | 2.36 | |
POCF ratio | 16.95 | 11.69 | 24.31 | 8.63 | 11.54 | |
PFCF ratio | 19.36 | 12.31 | 25.99 | -17.53 | 12.81 | |
P/B Ratio | 2.83 | 1.91 | 2.66 | 1.61 | 0.78 | |
PTB ratio | 2.83 | 1.91 | 2.66 | 1.61 | 0.78 | |
EV to sales | 5.27 | 3.25 | 4.42 | 2.3 | 0.99 | |
Enterprise value over EBITDA | 18.03 | 11.06 | 11 | 8.55 | 2.78 | |
EV to operating cash flow | 14.46 | 8.56 | 18.36 | 6.48 | 4.85 | |
EV to free cash flow | 16.52 | 9.02 | 19.64 | -13.16 | 5.38 | |
Earnings yield | 0.04 | 0.06 | -0.04 | 0.08 | 0.13 | |
Free cash flow yield | 0.05 | 0.08 | 0.04 | -0.06 | 0.08 | |
Debt to equity | 0.02 | 0.05 | 0.05 | 0.03 | 0.02 | |
Debt to assets | 0.02 | 0.04 | 0.04 | 0.02 | 0.01 | |
Net debt to EBITDA | -3.1 | -4.04 | -3.56 | -2.84 | -3.84 | |
Current ratio | 3.21 | 4.5 | 3.72 | 2.42 | 3.32 | |
Interest coverage | 32.2 | 2.13K | 0 | 0 | -7.01 | |
Income quality | 1.28 | 1.49 | -1.07 | 1.17 | 0.65 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.09 | 0.13 | 0.08 | 0.09 | 0.24 | |
Research and developement to revenue | 0 | 0.07 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | -0.12 | -0.05 | -0.06 | -1.49 | -0.1 | |
Capex to revenue | -0.05 | -0.02 | -0.02 | -0.53 | -0.02 | |
Capex to depreciation | -1.39 | -0.62 | -0.52 | -15.5 | -0.4 | |
Stock based compensation to revenue | 0.04 | 0.03 | 0.41 | 0.02 | 0.01 | |
Graham number | 175.77 | 198.18 | 189.46 | 201.91 | 210.38 | |
ROIC | 0.09 | 0.08 | 0.23 | 0.11 | 0.09 | |
Return on tangible assets | 0.1 | 0.08 | -0.09 | 0.09 | 0.08 | |
Graham Net | 41.61 | 69.12 | 65.01 | 31.87 | 51.06 | |
Working capital | 3.51B | 5.26B | 4.9B | 3.23B | 4.41B | |
Tangible asset value | 6.18B | 7.87B | 7.28B | 8.14B | 9.5B | |
Net current asset value | 3.27B | 4.84B | 4.58B | 2.77B | 4.02B | |
Invested capital | 0.02 | 0.05 | 0.05 | 0.03 | 0.02 | |
Average receivables | 1.6B | 1.48B | 1.42B | 1.61B | 1.63B | |
Average payables | 320.57M | 335.39M | 715.36M | 415.76M | 94.37M | |
Average inventory | 1.25M | 4.54M | 8.29M | 5.25M | 11.86M | |
Days sales outstanding | 192.87 | 156.82 | 151.66 | 157.73 | 165.68 | |
Days payables outstanding | 0 | 152 | 184.42 | 12.05 | 27.45 | |
Days of inventory on hand | 0.65 | 1.49 | 2.43 | 0.09 | 5.44 | |
Receivables turnover | 1.89 | 2.33 | 2.41 | 2.31 | 2.2 | |
Payables turnover | 0 | 2.4 | 1.98 | 30.3 | 13.3 | |
Inventory turnover | 562.95 | 244.46 | 150.51 | 4.25K | 67.13 | |
ROE | 0.12 | 0.11 | -0.12 | 0.12 | 0.1 | |
Capex per share | -2.19 | -1.07 | -0.83 | -33.81 | -0.92 |
Quarterly Fundamentals Overview
Last date of statement is 2023-09-30 for Q3
Metric | History | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 9.89 | 12.67 | 11.57 | 6.78 | 10.84 | |
Net income per share | 2.64 | 2.01 | 3.52 | 2.27 | 3.37 | |
Operating cash flow per share | 0.38 | 0.91 | 1.23 | 0.18 | 0.81 | |
Free cash flow per share | 0.38 | 0.07 | 1.23 | 0.18 | 0.81 | |
Cash per share | 63.74 | 67.82 | 72.4 | 37.31 | 77.55 | |
Book value per share | 134.4 | 135.15 | 138.58 | 71.77 | 147.49 | |
Tangible book value per share | 135.83 | 136.51 | 139.94 | 72.45 | 148.86 | |
Share holders equity per share | 134.4 | 135.15 | 138.58 | 71.77 | 147.49 | |
Interest debt per share | 1.7 | 2.68 | 0.85 | -0.52 | 1.12 | |
Market cap | 6.51B | 7.44B | 7.9B | 14.19B | 6.3B | |
Enterprise value | 2.3B | 3.2B | 3.28B | 9.53B | 1.42B | |
P/E ratio | 8.93 | 13.29 | 8.09 | 11.25 | 6.75 | |
Price to sales ratio | 9.52 | 8.43 | 9.83 | 15.07 | 8.4 | |
POCF ratio | 246.83 | 116.96 | 92.38 | 582.75 | 112.65 | |
PFCF ratio | 246.83 | 1.48K | 92.38 | 582.75 | 112.65 | |
P/B Ratio | 0.7 | 0.79 | 0.82 | 1.42 | 0.62 | |
PTB ratio | 0.7 | 0.79 | 0.82 | 1.42 | 0.62 | |
EV to sales | 3.36 | 3.63 | 4.08 | 10.12 | 1.89 | |
Enterprise value over EBITDA | 9.63 | 12.49 | 11.21 | 26.97 | 5.93 | |
EV to operating cash flow | 87.22 | 50.36 | 38.36 | 391.34 | 25.37 | |
EV to free cash flow | 87.22 | 636.46 | 38.36 | 391.34 | 25.37 | |
Earnings yield | 0.03 | 0.02 | 0.03 | 0.02 | 0.04 | |
Free cash flow yield | 0 | 0 | 0.01 | 0 | 0.01 | |
Debt to equity | 0.01 | 0.02 | 0.01 | -0.01 | 0.01 | |
Debt to assets | 0.01 | 0.01 | 0.01 | -0.01 | 0.01 | |
Net debt to EBITDA | -17.62 | -16.52 | -15.79 | -13.19 | -20.41 | |
Current ratio | 3.68 | 3.32 | 3.17 | 3.21 | 3.48 | |
Interest coverage | 13.76 | 11.39 | -7.99 | 0 | 0 | |
Income quality | 0.99 | 3.24 | 2.4 | 0.54 | 1.74 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.08 | 0.36 | 0.06 | 0.07 | 0.09 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0 | -0.92 | 0 | 0 | 0 | |
Capex to revenue | 0 | -0.07 | 0 | 0 | 0 | |
Capex to depreciation | 0 | -0.51 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0.04 | 0 | 0 | 0 | |
Graham number | 89.27 | 78.19 | 104.7 | 60.54 | 105.77 | |
ROIC | 0.02 | 0.02 | 0.02 | 0.03 | 0.02 | |
Return on tangible assets | 0.02 | 0.01 | 0.02 | 0.03 | 0.02 | |
Graham Net | 49.64 | 50.14 | 51.4 | 26.93 | 57.72 | |
Working capital | 4.39B | 4.41B | 4.52B | 4.71B | 4.9B | |
Tangible asset value | 9.4B | 9.5B | 9.72B | 10.07B | 10.3B | |
Net current asset value | 3.98B | 4.02B | 4.15B | 4.34B | 4.55B | |
Invested capital | 0.01 | 0.02 | 0.01 | -0.01 | 0.01 | |
Average receivables | 1.55B | 1.41B | 1.33B | 1.27B | 1.24B | |
Average payables | 0 | 58.57M | 58.57M | 75.53M | 75.53M | |
Average inventory | 6.5M | 16.76M | 79.64M | 139.66M | 148.58M | |
Days sales outstanding | 186.54 | 143.59 | 139.41 | 124.73 | 140.16 | |
Days payables outstanding | 0 | 71.89 | 0 | 35.3 | 0 | |
Days of inventory on hand | 2.71 | 14.24 | 33.09 | 33.48 | 34.56 | |
Receivables turnover | 0.48 | 0.63 | 0.65 | 0.72 | 0.64 | |
Payables turnover | 0 | 1.25 | 0 | 2.55 | 0 | |
Inventory turnover | 33.27 | 6.32 | 2.72 | 2.69 | 2.6 | |
ROE | 0.02 | 0.01 | 0.03 | 0.03 | 0.02 | |
Capex per share | 0 | -0.84 | 0 | 0 | 0 |
NOAH Frequently Asked Questions
What is Noah Holdings Limited stock symbol ?
Noah Holdings Limited is a CN stock and trading under the symbol NOAH
Is Noah Holdings Limited buy or a sell ?
2 stock analysts have 2 predictions with a medium analyst target price of $22.75. The lowest prediction is $15 and the highest is $30.5
What is NOAH stock prediction ?
What is Noah Holdings Limited stock quote today ?
Noah Holdings Limited stock price is $11.43 today.
Is Noah Holdings Limited stock public?
Yes, Noah Holdings Limited is a publicly traded company.